The FDA suspends the use of a Glaxo antibody drug in the US if an Omicron subvariant spreads.
Federal regulators said they are suspending use of a monoclonal antibody drug known as sotrovimab to treat high-risk Covid-19 patients ...
Friday, August 19, 2022
ADVERTISEMENT
ADVERTISEMENT
Tag: Glaxo
A Glaxo antibody drug is restricted in the northeastern US if an Omicron subvariant spreads.
Federal health officials Friday restricted the use of a monoclonal antibody Covid drug in eight northeast states and two territories, ...
